Report: Lung cancer rates dropping because of better access, screening, treatment

A new report offers hope on the lung cancer front: Overall cancer rates are being driven down because patients are being diagnosed at an earlier stage in their disease and living longer due to better access to care, higher screening rates and improved treatments (Source: “Progress on Lung Cancer Drives Overall Decline in U.S. Cancer Deaths,” HealthDay News, Jan. 12).

Still, lung cancer remains the leading cause of cancer death in the country, according to the annual Cancer Statistics report conducted by the American Cancer Society and released Wednesday.

In 2018, 28% of lung cancers were detected at a localized stage, compared with 17% in 2004. Nearly one-third (31%) of lung patients now survive three years past diagnosis, compared to 21% a decade ago.

But lung cancer still causes 350 deaths a day -- more than breast, prostate and pancreatic cancers combined -- and is responsible for the most cancer deaths by far, according to the report.

Attend HPIO's 2025 Health Policy Summit on Oct. 9, 2025

With limited resources and growing need, investing in policies that deliver the greatest impact is essential. This event will highlight strategies that improve health and wellbeing while reducing healthcare spending. Speakers will provide evidence-informed research responsive to today’s political climate, focusing on what works and why it matters now more than ever.

Register now